BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Accenture
Moodys
Chubb
AstraZeneca
Argus Health
Johnson and Johnson
Cipla
UBS

Generated: January 18, 2018

DrugPatentWatch Database Preview

CHLOROTHIAZIDE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Chlorothiazide Sodium, and when can generic versions of Chlorothiazide Sodium launch?

Chlorothiazide Sodium is a drug marketed by Fresenius Kabi Usa, Luitpold, Mylan Institutional, Sagent Pharms, and Sun Pharma Global. and is included in five NDAs.

The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Drug patent expirations by year for CHLOROTHIAZIDE SODIUM
Pharmacology for CHLOROTHIAZIDE SODIUM
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for CHLOROTHIAZIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 090896-001 Oct 16, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202462-001 May 29, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202561-001 Apr 22, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202493-001 Jun 18, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 091546-001 Jul 26, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Chubb
Farmers Insurance
Accenture
Novartis
Moodys
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot